OUR SERVICES
Deep strategic and technical expertise
Market Access and HTA Strategy
Strategic access planning, roadmap and evidence planning, HTA strategy and submission support
Literature review
Systematic and other literature reviews, including to support HTA submissions
Health Economic Modelling
Cost effectiveness, budget impact, decision analytic, Early HTA models, Pricing analyses
Patient Centered Research
Utility generation for HTA, HRQoL studies, PROM development and validation, Patient preference studies
Real-World Evidence
Epidemiology, treatment pathways, resource utilisation, comparative safety/effectiveness
Biostatistics
Indirect treatment comparisons (NMA, MAIC, etc.), Post-hoc clinical trial analyses
Experienced leaders
100+
Years of Experience
400+
Scientific publications
40+
HTA submissions
ABOUT
Experts in HEOR and market access
Arrow Health Economics provide class-leading market access and health economics services to a select group of pharmaceutical and biotech clients.
Our team combine strategic expertise with deep technical knowledge in key evidence generation domains including economic modelling, patient-centered research, real-world evidence, biostatistics and literature review.
We believe the best outcomes are achieved when working in close partnership with our clients. In line with this, we ensure our senior leaders support our clients, from project inception, through delivery and beyond. This approach allows us to ensure our projects are designed and delivered with a clear understanding of our clients' broad strategic aims and a greater appreciation for where we can add additional value.
Where needed, we have an extensive network of experts in market access, HTA, health economics, as well as clinical experts and patient advocates, across all major European countries to provide feedback on payer needs and the evolving external access environment.
